We sync with 95% of all diabetes devices, delivering trusted data, in a simple and usable platform
Glooko® Enterprise Comprehensive In-Clinic and Remote Diabetes Management Package
Introducing our latest product update on Glooko® Enterprise, you can benefit from:
Glooko Care Programs - Enroll your patients and onboard them to use Glooko, as well as provide educational resources and best practices about their diabetes. Contact us today to upgrade to Glooko® Enterprise and learn how you and your patients can benefit from the complete Glooko experience.
Compatible Data Sources
- BGMs / CGMs / pumps
- Connected smart pens
- Health apps
- Remote data uploading
Professional Tools & Support
- Glooko Population Tracker
- Glooko Transmitter
- Account Management
Remote Programs
- Glooko Mobile App (Free*)
- Glooko Remote Monitoring
- Glooko Mobile Insulin Dosing System (MIDS)
*one-time hardware cost may apply
Clinic Reporting Packages
Monthly analytics package providing key insights to manage patient populations
Glooko Enterprise Additional Options
Glooko EHR Integrations
Streamline Workflow And Improve Data Accessibility
Remote Patient Monitoring (RPM) Billing Reports
• Easy access to data needed for reimbursement.
Glooko Pop Health Analytics
Health system level decision making
Identify at-risk patients to provide proactive outreach
Understand real world outcomes related to diabetes and how patient populations respond to specific interventions
FDA-cleared Digital Therapeutics
Glooko Mobile Insulin Dosing System (MIDS)
FDA-cleared long-acting Insulin (LAI) dosing system
Simplify the process of titrating insulin doses between provider visits
Use insulin treatment plans that are easy to create, fast to share, and simple to follow
Get automatic recommendations for the appropriate LAI doses according to the parameters set by the clinician and patients’ synced BG readings and confirmed LAI doses
Patients receive the right dose of insulin in a supported manner in between visits
Glooko Improves Outcomes
People with diabetes that are remotely monitored using the Glooko Mobile App experience the following
Decreased Average BG*
- 14.4% at 3 months
- 15.4 after 6 months
- 19.2 after one year
Increased In Range BG*
- 17% at 3 months
- 18% after 6 months
- 23.7% after one year
Decreased Hyperglycemia*
- 11.4% at 3 months
- 13.5% after 6 months
- 15.1% after one year
*Data on file
Privacy & Security
We are a trusted partner
- Proactive threat monitoring to identify and respond to threats
- Ongoing vulnerability scanning to continually improve security of the platform
- Active availability and performance monitoring to ensure platform responsiveness and rapid response to issues
- 3rd party objective assessments , including yearly penetration testing and cybersecurity risk assessment
- HIPAA and GDPR ready
- Ethical, legal, principled use of data baked into policies and culture